DIALYSIS · CCN 142554

FMC - NEOMEDICA - MELROSE PARK

MELROSE PARK, IL 60160

DialysisProfitFresenius Medical Care
$3.6M
TOTAL REVENUE
27.7%
OPERATING MARGIN
4 / 5
STAR RATING
15
QUALITY MEASURES
Fresenius Medical Care
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.6M
Total costs
$2.6M
Operating income (rev − costs)
$1.0M
Operating margin
27.7%
Total charges
$3.6M
Total treatments
9,966
Dialysis stations
18

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9984—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.9347—
Fistula Rate
DFC_FISTULA_RATE
69.590—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.7726—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
131.667—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
089—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.41——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1290—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
17257—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
12.582—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
24.761—
Standardized ED Visits Ratio
DFC_SEDR
1.3529—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
39.123—